Terms: = Kidney tumors AND COL1A1, P02452, 1277, ENSG00000108821, OI4
19 results:
1. Open versus robotic partial nephrectomy in obese patients: a multi-institutional propensity score-matched analysis (UroCCR 43-Robese study).
Beauval JB; Khene ZE; Roumiguié M; Rahota R; Mejean A; Doumerc N; Roupret M; Paparel P; Villers A; Bruyere F; Lebacle C; Nouhaud FX; Champy C; de la Taille A; Lang H; Rizk J; Durand M; Dariane C; Charles T; Boissier R; Long JA; Bigot P; Bensalah K; Bernhard JC
World J Urol; 2024 Apr; 42(1):213. PubMed ID: 38581466
[TBL] [Abstract] [Full Text] [Related]
2. hsa_circ_0020378 regulating miR-339-3p/col1a1 promotes osteosarcoma progression.
Liu L; Huang W
Cancer Biol Ther; 2023 Dec; 24(1):2274120. PubMed ID: 37978903
[TBL] [Abstract] [Full Text] [Related]
3. Soluble dipeptidyl peptidase-4 induces epithelial-mesenchymal transition through tumor growth factor-β receptor.
Huang CW; Lee SY; Du CX; Ku HC
Pharmacol Rep; 2023 Aug; 75(4):1005-1016. PubMed ID: 37233949
[TBL] [Abstract] [Full Text] [Related]
4. Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis.
Liu Z; Yang Z; Li J; Liu Z; Ma N; Chen P; Bi X; Li Z; Dong P; Han H; He X; Mao X; Guo S
Asian J Surg; 2023 Sep; 46(9):3607-3613. PubMed ID: 37147255
[TBL] [Abstract] [Full Text] [Related]
5. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis.
Psutka SP; Gulati R; Jewett MAS; Fadaak K; Finelli A; Legere L; Morgan TM; Pierorazio PM; Allaf ME; Herrin J; Lohse CM; Houston Thompson R; Boorjian SA; Atwell TD; Schmit GD; Costello BA; Shah ND; Leibovich BC
Eur Urol; 2022 Jun; 81(6):576-585. PubMed ID: 34862099
[TBL] [Abstract] [Full Text] [Related]
6. A construction and comprehensive analysis of ceRNA networks and infiltrating immune cells in papillary renal cell carcinoma.
Fan Y; Dai F; Yuan M; Wang F; Wu N; Xu M; Bai Y; Liu Y
Cancer Med; 2021 Nov; 10(22):8192-8209. PubMed ID: 34598322
[TBL] [Abstract] [Full Text] [Related]
7. COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis.
Ding YL; Sun SF; Zhao GL
Medicine (Baltimore); 2021 Feb; 100(7):e24561. PubMed ID: 33607786
[TBL] [Abstract] [Full Text] [Related]
8. Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers.
Chen J; Lou W; Ding B; Wang X
Aging (Albany NY); 2019 Aug; 11(15):5666-5688. PubMed ID: 31409759
[TBL] [Abstract] [Full Text] [Related]
9. Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
Yamada Y; Sugawara S; Arai T; Kojima S; Kato M; Okato A; Yamazaki K; Naya Y; Ichikawa T; Seki N
Int J Urol; 2018 Nov; 25(11):953-965. PubMed ID: 30153702
[TBL] [Abstract] [Full Text] [Related]
10. Check point inhibitors a new era in renal cell carcinoma treatment.
Alsharedi M; Katz H
Med Oncol; 2018 May; 35(6):85. PubMed ID: 29728867
[TBL] [Abstract] [Full Text] [Related]
11. Induction of type 1 iodothyronine deiodinase expression inhibits proliferation and migration of renal cancer cells.
Poplawski P; Rybicka B; Boguslawska J; Rodzik K; Visser TJ; Nauman A; Piekielko-Witkowska A
Mol Cell Endocrinol; 2017 Feb; 442():58-67. PubMed ID: 27940296
[TBL] [Abstract] [Full Text] [Related]
12. The benefits of cancer screening in kidney transplant recipients: a single-center experience.
Kato T; Kakuta Y; Abe T; Yamanaka K; Imamura R; Okumi M; Ichimaru N; Takahara S; Nonomura N
Cancer Med; 2016 Feb; 5(2):153-8. PubMed ID: 26686199
[TBL] [Abstract] [Full Text] [Related]
13. Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer.
Boguslawska J; Kedzierska H; Poplawski P; Rybicka B; Tanski Z; Piekielko-Witkowska A
J Urol; 2016 Jun; 195(6):1892-902. PubMed ID: 26631499
[TBL] [Abstract] [Full Text] [Related]
14. Systematic review of hepatocellular carcinoma mortality rates among hepatitis B virus-infected renal transplant recipients, with supplemental analyses of liver failure and all-cause mortality.
Blackadar CB
Int J Infect Dis; 2013 Jan; 17(1):e24-36. PubMed ID: 23036372
[TBL] [Abstract] [Full Text] [Related]
15. [Partial elective nephrectomy].
Zungri E; Martínez L; Leal D; Lorenzo L
Actas Urol Esp; 2012 Mar; 36(3):160-4. PubMed ID: 21955560
[TBL] [Abstract] [Full Text] [Related]
16. [Screening of differentially expressed genes in human renal cell carcinoma using suppression subtractive hybridization].
Wang Y; Chen W; Li X
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):89-93. PubMed ID: 18227036
[TBL] [Abstract] [Full Text] [Related]
17. Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
Ibanez de Caceres I; Dulaimi E; Hoffman AM; Al-Saleem T; Uzzo RG; Cairns P
Cancer Res; 2006 May; 66(10):5021-8. PubMed ID: 16707423
[TBL] [Abstract] [Full Text] [Related]
18. [Etiology, diagnosis and management of spontaneous per renal hemorrhage].
Yu ZX; Xia GP; Hu WH; Chen W; Li XB; Chen HD; Lin LZ; Deng ZX; Cai B; Weng ZL
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):39-41. PubMed ID: 16606534
[TBL] [Abstract] [Full Text] [Related]
19. Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group.
Kalapurakal JA; Li SM; Breslow NE; Beckwith JB; Macklis R; Thomas PR; D'Angio GJ; Kim T; de Lorimier A; Kelalis P; Shochat S; Ritchey M; Haase G; Hrabovsky E; Otherson HB; Grundy P; Green DM;
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):495-9. PubMed ID: 12957262
[TBL] [Abstract] [Full Text] [Related]
